United States - English - NLM (National Library of Medicine)

team technologies, inc - stannous fluoride (unii: 3ftr44b32q) (fluoride ion - unii:q80vpu408o) - anticavity, antigingivitis, antisensitivity - aids in the prevention of cavities - helps prevent gingivitis - helps interfere with harmful effects of plaque associated with gingivitis - builds increasing protection against painful sensitivity of the teeth to cold, heat, acids, sweets, or contact

United States - English - NLM (National Library of Medicine)

team technologies, inc - chlorhexidine gluconate (unii: mor84mud8e) (chlorhexidine - unii:r4ko0dy52l) - chlorhexidine gluconate oral rinse should not be used by persons who are known to be hypersensitive to chlorhexidine gluconate or other formula ingredients.

United States - English - NLM (National Library of Medicine)

team technologies, inc - stannous fluoride 0.454%......................  anticavity, antigingivitis, (0.16% w/v fluoride ion)                             antisensitivity toothpaste  - - helps aid in the prevention of cavities - helps prevent gingivitis - helps control plaque bacteria that contribute to the development of gingivitis - build increasing protection against painful sensitivity of the teeth to cold, heat, acids, sweets or contact. anticavity, antigingivitis, antisensitivity toothpaste

United States - English - NLM (National Library of Medicine)

team technologies, inc. - stannous fluoride (unii: 3ftr44b32q) (fluoride ion - unii:q80vpu408o) - anticavity, antigingivitis, antisensitivity - aids in the prevention of cavities - helps prevent gingivitis - helps interfere with harmful effects of plaque associated with gingivitis - builds increasing protection against painful sensitivity of the teeth to cold, heat, acids, sweets, or contact

United States - English - NLM (National Library of Medicine)

team technologies, inc - - builds increasing protection against painful sensitivity of teeth due to cold, heat, acids, sweets or contact - aids in the prevention of dental cavities antihypersensitivity, anticavity

United States - English - NLM (National Library of Medicine)

team technologies, inc - - builds increasing protection against painful sensitivity of teeth due to cold, heat, acids, sweets or contact - aids in the prevention of dental cavities

United States - English - NLM (National Library of Medicine)

team technologies, inc - - builds increasing protection against painful sensitivity of teeth due to cold, heat, acids, sweets or contact - aids in the prevention of dental cavities

United States - English - NLM (National Library of Medicine)

team technologies, inc - - builds increasing protection against painful sensitivity of teeth due to cold, heat, acids, sweets or contact - aids in the prevention of dental cavities

United States - English - NLM (National Library of Medicine)

leadiant biosciences, inc. - cysteamine hydrochloride (unii: if1b771svb) (cysteamine - unii:5ux2sd1ke2) - cysteamine hydrochloride 6.5 mg in 1 ml - cystaran is a cystine-depleting agent indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis. none. risk summary there are no adequate and well controlled studies of ophthalmic cysteamine in pregnant women to inform any drug associated risks. oral administration of cysteamine to pregnant rats throughout the period of organogenesis was teratogenic at doses 86 to 345 times the recommended human ophthalmic dose (based on body surface area) [see data] . cystaran should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. data animal data teratology studies have been performed in rats at oral doses in the range of 37.5 mg/kg/day to 150 mg/kg/day (86 to 345 times the recommended human ophthalmic dose based on a body surface area) and have revealed cysteamine bitartrate to be teratogenic. observed teratogenic findings were intrauterine death, cleft palate, kyphosis, heart ventricular septal defects, microcephaly, exe

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - cysteamine bitartrate (unii: qo84gz3tst) (cysteamine - unii:5ux2sd1ke2) - cysteamine 50 mg - cystagon® is indicated for the management of nephropathic cystinosis in children and adults. cystagon® is contraindicated in patients who have developed hypersensitivity to it or to cysteamine or penicillamine. cystagon® has not been associated with abuse potential, psychological or physical dependence in humans.